Strongid-P Paste 43.90% w/w

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Pyrantel Embonate

Available from:

Elanco Europe Ltd

INN (International Name):

Pyrantel Embonate

Pharmaceutical form:

Oral paste

Prescription type:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Therapeutic group:

Donkey, Horses

Therapeutic area:

Anthelmintic

Authorization status:

Authorized

Authorization date:

1994-05-23

Summary of Product characteristics

Revised: November 2022
AN: 01625/2022
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Strongid-P Paste 43.90% w/w
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE
Pyrantel Embonate 43.90 %w/w
For a full list of excipients see section 6.1
3.
PHARMACEUTICAL FORM
Oral paste.
A smooth, pale yellow to buff paste for oral administration.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses, ponies, donkeys and foals over four weeks of age.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
A broad spectrum anthelmintic for use in horses and donkeys for the
control and
treatment of adult infections of large and small strongyles, _Oxyuris,
Parascaris _and
_Anoplocephala perfoliata._
Effective against benzimidazole resistant strains of small strongyles.
4.3
CONTRAINDICATIONS
Not for use in horses with known hypersensitivity to the active
ingredient.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk
of development of resistance and could ultimately result in
ineffective therapy:
•
Too frequent and repeated use of anthelmintics from the same class,
over
an extended period of time.
•
Underdosing, which may be due to underestimation of body weight,
misadministration of the product, or lack of calibration of the dosing
device
(if any).
Revised: November 2022
AN: 01625/2022
Page 2 of 5
Suspected clinical cases of resistance to anthelmintics should be
further investigated
using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where
the results of
the test(s) strongly suggest resistance to a particular anthelmintics
belonging to
another pharmacological class and having a different mode of action
should be used.
Resistance
to
pyrantel
has
been
reported
in
cyathostomes
in
horses
(also
widespread in the US and Canada). Therefore the use of this product
should be
based on a local (regional, farm) epidemiological information about
susceptibility of
nematodes and recommendations on how to limit furt